Useful resources |
Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma (Cochrane Review) ABSTRACT Background: Paclitaxel has become a standard drug used in a number of common cancers. At first long infusions were used to reduce the rate of inflow of the drug and as a result reduce the occurrence of hypersensitivity types of allergic reactions. Trials with sh . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |